Natco Pharma Quarterly Results for Trading Insights

NATCOPHARM • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹518 Cr
QSept 2025
Quarterly Results

Natco Pharma Quarterly Results Key Highlights

  • Revenue of ₹1,463 Cr in Sept 2025 (+13.7% vs Mar 2025, +2.0% vs Sept 2024)
  • Net Profit of ₹518 Cr in Sept 2025 (+27.6% vs Mar 2025, -23.5% vs Sept 2024)
  • EBITDA of ₹679 Cr in Sept 2025 (+10.6% vs Mar 2025)
  • Operating Margin of 42.0% in Sept 2025 (-3.0pp vs Mar 2025)
  • Earnings Per Share of ₹28.94 in Sept 2025 (+27.5% vs Mar 2025)

Natco Pharma Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 1,463 1,287 1,391 705 1,435 13.7% 2.0%
Net Profit (₹ Cr) 518 406 480 151 677 - -
EBITDA (₹ Cr) 679 614 633 217 868 - -
EPS (₹) 28.94 22.70 26.84 8.46 37.81 - -
Operating Margin (%) 42.0% 45.0% 43.0% 25.0% 59.0% - -

Natco Pharma Share Price Trend Around Quarterly Results

Visualize Natco Pharma's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Natco Pharma

Additional stock information and data for NATCOPHARM

NATCOPHARM stock price BSE
Natco Pharma price earnings
NATCOPHARM yearly price range

Profitability Ratios

Profit Margin 35.4%
EBITDA Margin 46.4%
Operating Margin 42.0%
ROE (Annual) 27.2%

Balance Sheet Highlights

Total Assets ₹8,631 Cr
Total Equity ₹7,612 Cr
Current Assets ₹5,270 Cr
Current Liabilities ₹75 Cr

Cash Flow Analysis

Operating Cash Flow ₹1,697 Cr
Investing Cash Flow ₹-1,437 Cr
Financing Cash Flow ₹-211 Cr
Net Cash Flow ₹50 Cr

Current Market Data

Current Price ₹974.20
Exchange NSE
Last Updated Mar 30, 2026

Revenue Trend (₹ Cr)

Dec 2025 705
Jun 2025 1,391
Mar 2025 1,287
Sept 2025 1,463

Net Profit Trend (₹ Cr)

Dec 2025 151
Jun 2025 480
Mar 2025 406
Sept 2025 518

Operating Margin Trend (%)

Dec 2025 25.0%
Jun 2025 43.0%
Mar 2025 45.0%
Sept 2025 42.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Natco Pharma quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹430,344.72 Cr 1757.2 14,875 3,125 +10.8% - 21.0% 135.2
Divis Laboratories
Sept 2025 		₹159,214.78 Cr 5947.0 2,860 689 +7.1% - 24.1% 229.0
Torrent Pharmaceuti…
Sept 2025 		₹144,367.29 Cr 4220.2 3,219 591 +11.3% - 18.4% 240.6
Lupin
Sept 2025 		₹107,238.09 Cr 2313.9 6,921 1,485 +23.2% - 21.5% 71.5
Dr Reddys Laborator…
Sept 2025 		₹106,974.57 Cr 1254.9 9,135 1,337 +1.1% - 14.6% 77.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores